Depemokimab (anti-IL-5) is a humanized monoclonal antibody (IgG1, kappa) directed against IL-5. Depemokimab (anti-IL-5) can be used for research of asthma.
Product Properties
Isotype
Human IgG1
Light Chain Type
kappa
SDS-PAGE
145.8 kDa
Purification Method
Protein A purified
Purity
>95% (SDS-PAGE&SEC)
Form
Liquid
Concentration
Lot by Lot
Storage Temp
Store at -80°C,Avoid repeated freezing and thawing
Shipped In
Ice chest + Ice pads
Stability And Storage
Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS
2243274-14-6
Images
Depemokimab (anti-IL-5) (Ab182926) - ELISA Immobilized Human IL-5-His Tag Protein at 2.0 μg/mL can bind Depemokimab (anti-IL-5) (Ab182926) with the EC
₅₀
of 96.02 ng/mL.
Depemokimab (anti-IL-5) (Ab182926) - SEC The purity of Depemokimab (anti-IL-5) (Ab182926) is more than 95% verified by HPLC.